Načítá se...

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most fatal cancers, and its molecular basis needs to be delineated to identify biomarkers for its potential treatment. The purpose of this study was to identify a novel gene, nucleosome assembly proteins 1-like 1 protein (NAP1L1), associated w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Cell Int
Hlavní autoři: Le, Yong, Kan, Anna, Li, Qi-Jiong, He, Min-Ke, Chen, Hai-Long, Shi, Ming
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6729091/
https://ncbi.nlm.nih.gov/pubmed/31516385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0949-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!